Free Trial
→ Reagan’s former tech advisor sharing bombshell announcement (From Banyan Hill Publishing) (Ad)tc pixel

CSL (OTCMKTS:CSLLY) Shares Gap Down - Here's What Happened

Written by MarketBeat
September 13, 2025
CSL logo with Medical background

Key Points

  • CSL Limited's shares experienced a significant gap down, opening at $67.50 after a previous close of $69.48 before last trading at $68.00.
  • The company's financial ratios include a quick ratio of 0.85 and a current ratio of 1.86, indicating potential liquidity concerns.
  • CSL operates through multiple segments, notably CSL Behring, which focuses on plasma products, gene therapies, and recombinants, highlighting its diverse biopharmaceutical offerings.
  • Five stocks to consider instead of CSL.

CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report) shares gapped down prior to trading on Thursday . The stock had previously closed at $69.48, but opened at $67.50. CSL shares last traded at $68.00, with a volume of 2,461 shares.

CSL Trading Down 1.6%

The company has a quick ratio of 0.85, a current ratio of 1.86 and a debt-to-equity ratio of 0.45. The business's fifty day moving average is $79.62 and its 200-day moving average is $79.09.

About CSL

(Get Free Report)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CSL Right Now?

Before you consider CSL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.

While CSL currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.